The global electrophysiological market is expected to rise at a considerable rate during the forecast period. In 2021, the market is growing steadily and is expected to rise above the projected horizon because of the strategy adopted by key players.
Important developments in commercial electrophysiological device technology, a rise in diseases and an ageing population around the world, an increase in arrhythmia instances, and the global expansion of significant players are all projected to have a positive impact on the electrophysiology market. In the upcoming years, the use of new mapping and guidance techniques that help with improved heart rhythm monitoring will increase the adoption of electrophysiological devices. As a result, the electrophysiology sector will develop throughout the projected period as a result of rising atrial fibrillation rates and technological advancements.
The Electrophysiology Market is anticipated to grow as target diseases and treatments become more prevalent. The most frequent arrhythmia to be identified in clinical settings is AF. The global market will expand as cardiac arrhythmias become more commonplace worldwide. Arrhythmias with a high prevalence of diagnosis include atrial fibrillation (AFib), a kind of abnormal heart rhythm. Using electrophysiology, patients can identify and treat cardiac arrhythmias. The expansion of major companies throughout the world and technological advancements in commercial electrophysiological devices are two important aspects that are anticipated to enhance the market for these products. The introduction of new mapping and guidance techniques that aid in improved heart rhythm monitoring will also increase the use of electrophysiological devices.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD BILLION), (THOUSAND UNITS) |
| Segmentation | By type, by route, by facility of use, by region |
| By Product
|
|
| By Indication
|
|
| By End-User
|
|
| By Region
|
|
The global electrophysiology market is expected to develop as a result of the rising incidence of heart failure (HF) and cardiac arrest cases among millennials, which are linked to lifestyle choices including smoking and binge drinking. There are several limitations and difficulties that will impede the expansion of the market as a whole. The market expansion is being constrained by problems like a lack of people with sophisticated medical knowledge, a lack of standards, and a lack of protocols. Additionally, it is predicted that the slow expansion throughout the forecast period will be caused by the high cost of electrophysiological products and insufficient reimbursement. The majority of electrophysiological goods are pricey, including cardiac 3D mapping equipment, EP recording systems, and generally pricy EP procedures. These products also have substantial capital, training, and maintenance costs.
Vendors of electrophysiology are anticipated to experience significant growth prospects in the emerging regions. This is because there are more patients, more people with disposable cash, better healthcare infrastructure, and more lax regulations than in industrialized nations. Due to an expanding target patient population, an increase in CVD-related fatalities, and increased medical tourism, the emerging countries have seen a consistent rise in surgical procedures over the past ten years.
However, price competition in the market for electrophysiological equipment is fierce. Most of the devices in cardiac electrophysiology are high-end, with 3D mapping systems and E.P. recording high systems costs. E.P. methods are typically expensive, which is restricting the industry's expansion because of the high capital, training, and maintenance costs.
Healthcare systems all across the world have faced significant hurdles as a result of the COVID-19 pandemic, which has mainly been contained by dramatically reducing in- and outpatient treatments for illnesses and enacting infection prevention and control measures. Access to the facility and visitors by nonclinical employees was constrained in several nations. Additionally, the higher frequency of cardiovascular diseases among COVID-19 patients increased demand for electrophysiology investigations, leading to faster market expansion. In accordance with the most recent COVID-19 standards for healthcare professionals, urgent treatment should take priority, and cases should be triaged in order to postpone elective procedures and clinic visits and as necessary, switch to virtual-based care. As a result, the COVID-19 pandemic had a brief detrimental effect on the electrophysiology industry.
The electrophysiology market is expected to grow at 10.31 % CAGR from 2022 to 2029. It is expected to reach above USD 15.71 billion by 2029 from USD 6.5 billion in 2020.
North America accounted held the largest market share for the Electrophysiology Market in 2021. The market for topical drug delivery in North America is anticipated to grow at a CAGR of 9.66% from 2022 to 2029. The size of the Electrophysiology Market in North America is predicted to worth USD 3.13 billion in 2022.
Important developments in commercial electrophysiological device technology, a rise in diseases and an ageing population around the world, an increase in arrhythmia instances, and the global expansion of significant players are all projected to have a positive impact on the electrophysiology market.
The major players in the Electrophysiology Market include Abbott Laboratories (U.S.), Biosense Webster, Inc. (U.S.), BIOTRONIK SE & Co. KG (Germany), Boston Scientific Corporation (U.S.), GE Healthcare (U.K.), Koninklijke Philips N.V. (The Netherlands), Medtronic, Inc. (U.S.), Microport Scientific Corporation (China), St. Jude Medical, Inc. (U.S.), and Siemens AG (Germany).
Arrhythmias with a high prevalence of diagnosis include atrial fibrillation (AFib), a kind of abnormal heart rhythm. Using electrophysiology, patients can identify and treat cardiac arrhythmias.
North America accounted held the largest market share for the Electrophysiology Market in 2021. The market for topical drug delivery in North America is anticipated to grow at a CAGR of 9.66% from 2022 to 2029. The topical medication delivery industry is seeing new growth due to increased research and development in this area.
The electrophysiology market is segmented based on Product ,Indication, End User.
In terms of product ablation catheters segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period. Ablation, a minimally invasive process that uses catheters to destroy the heart's damaged electrical circuits, is the basis for how ablation catheter’s function, which is a reason for the growth for this segment.
This market is divided into hospitals and cardiac centers and ambulatory surgery centers based on the end user segment. The market's largest category, hospitals & cardiac centers, accounts for 92.53% of total sales. A number of variables, including the presence of large Cath labs and electrophysiology labs in hospitals, an increase in the prevalence of CVDs, and a rise in the number of ablation treatments, are responsible for the substantial share of this end user sector. Demand for hospital-based care has been ensured by the availability of cutting-edge facilities for the diagnosis, treatment, and management of diseases, as well as skilled employees. Hospitals perform more screening and diagnostic operations than other types of healthcare facilities, which accounts for the huge percentage.
This market is divided into atrial fibrillation, atrioventricular nodal reentry tachycardia (AVNRT), Wolff-Parkinson-White (WPW) syndrome, atrial flutter, and other indications based on the kind of indication.
One of the most prevalent types of arrhythmias that causes erratic and fast heartbeats is atrial fibrillation (AF), commonly known as AFib. When the heart's upper chamber contracts rapidly due to fast electric signals, the atria are unable to pump blood into the ventricles normally, which leads to blood clots. Major heart-related problems including strokes and heart failure are more likely to occur in atrial fibrillation patients. AFib contributes to nearly one in every six strokes.
[caption id="attachment_16373" align="aligncenter" width="1920"]
North America accounted held the largest market share for the Electrophysiology Market in 2021. The market for topical drug delivery in North America is anticipated to grow at a CAGR of 9.66% from 2022 to 2029. The topical medication delivery industry is seeing new growth due to increased research and development in this area.
With a consistent CAGR through 2020, North America held the biggest market share for electrophysiology devices. It is mostly due to the region's developed healthcare infrastructure, an increase in cases of heart failure and arrhythmia, and technological improvements. According to research that was published in the International Journal of Stroke in January 2020, the US will have between 6 and 12 million people with atrial fibrillation by the year 2050.
Due to its established healthcare facilities, rising cases of arrhythmia and heart failure, strong industry players, improved healthcare infrastructure, and increased public and industry stakeholder awareness of the country's available technologies, the United States is predicted to dominate the global electrophysiology market in the future.
[caption id="attachment_16377" align="aligncenter" width="1920"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.